Showing results (241-250 of 31,336) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|March 30, 2011
Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphataseMedhanit Bahta, George T Lountos, Beverly Dyas, et al.Journal of Medicinal Chemistry|March 30, 2011
Organometallic half-sandwich iridium anticancer complexesZhe Liu, Abraha Habtemariam, Ana M Pizarro, et al.Journal of Medicinal Chemistry|March 30, 2011
Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activitiesShuhong Wu, Li Wang, Wei Guo, et al.Journal of Medicinal Chemistry|March 30, 2011
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatmentQian Cai, Haiying Sun, Yuefeng Peng, et al.Journal of Medicinal Chemistry|March 11, 2011
A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial propertiesPeter Angehrn, Erwin Goetschi, Hans Gmuender, et al.Journal of Medicinal Chemistry|March 17, 2011
Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitorsElisa M Nurminen, Marjo Pihlavisto, László Lázár, et al.Journal of Medicinal Chemistry|March 17, 2011
Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a novel anticancer agentYuanxiang Wang, Jing Ai, Ying Wang, et al.Journal of Medicinal Chemistry|January 1, 1990
Synthesis and serotonin binding site studies of some conformationally restricted indolylethylamine analogues based on 2-amino-3-(3'-indolyl)bicyclo[2.2.2]octaneM F Schlecht, D Tsarouhtsis, M N Lipovac, et al.Journal of Medicinal Chemistry|February 11, 2011
Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cellsVanna Sanna, Gianfranco Pintus, Anna Maria Roggio, et al.Journal of Medicinal Chemistry|February 15, 2011
Sugar-based enantiomeric and conformationally constrained pyrrolo[2,1-c][1,4]-benzodiazepines as potential GABAA ligandsAna C Araújo, Amélia P Rauter, Francesco Nicotra, et al.Pageof 3,134